Bilaketaren emaitzak - Nai‐Kong V. Cheung

Findu emaitzak
  1. 1
    Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma

    Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma nork Nai‐Kong V. Cheung

    Argitaratua 2012
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Engineering anti‐GD2 monoclonal antibodies for cancer immunotherapy

    Engineering anti‐GD2 monoclonal antibodies for cancer immunotherapy nork Mahiuddin Ahmed, Nai‐Kong V. Cheung

    Argitaratua 2013
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  3. 3
    GD2-Targeted Immunotherapy and Radioimmunotherapy

    GD2-Targeted Immunotherapy and Radioimmunotherapy nork Konstantin Dobrenkov, Nai‐Kong V. Cheung

    Argitaratua 2014
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  4. 4
    T cell engaging bispecific antibody (T-BsAb): From technology to therapeutics

    T cell engaging bispecific antibody (T-BsAb): From technology to therapeutics nork Zhanhong Wu, Nai‐Kong V. Cheung

    Argitaratua 2017
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays.

    Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cyto... nork David H. Munn, Nai‐Kong V. Cheung

    Argitaratua 1989
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Neuroblastoma: developmental biology, cancer genomics and immunotherapy

    Neuroblastoma: developmental biology, cancer genomics and immunotherapy nork Nai‐Kong V. Cheung, Michael A. Dyer

    Argitaratua 2013
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies

    Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies nork Sayed Shahabuddin Hoseini, Nai‐Kong V. Cheung

    Argitaratua 2017
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Limitations and opportunities for immune checkpoint inhibitors in pediatric malignancies

    Limitations and opportunities for immune checkpoint inhibitors in pediatric malignancies nork Jeong A Park, Nai‐Kong V. Cheung

    Argitaratua 2017
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Immunotherapy of Pediatric Solid Tumors: Treatments at a Crossroads, with an Emphasis on Antibodies

    Immunotherapy of Pediatric Solid Tumors: Treatments at a Crossroads, with an Emphasis on Antibodies nork Dana L. Casey, Nai‐Kong V. Cheung

    Argitaratua 2020
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Targets and Antibody Formats for Immunotherapy of Neuroblastoma

    Targets and Antibody Formats for Immunotherapy of Neuroblastoma nork Jeong A Park, Nai‐Kong V. Cheung

    Argitaratua 2020
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  11. 11
    GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma

    GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma nork Jeong A Park, Nai‐Kong V. Cheung

    Argitaratua 2020
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Acute myeloid leukemia targets for bispecific antibodies

    Acute myeloid leukemia targets for bispecific antibodies nork Sayed Shahabuddin Hoseini, Nai‐Kong V. Cheung

    Argitaratua 2017
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Promise and Challenges of T Cell Immunotherapy for Osteosarcoma

    Promise and Challenges of T Cell Immunotherapy for Osteosarcoma nork Jeong A Park, Nai‐Kong V. Cheung

    Argitaratua 2023
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Immunotherapy of Childhood Sarcomas

    Immunotherapy of Childhood Sarcomas nork Stephen S. Roberts, Alexander J. Chou, Nai‐Kong V. Cheung

    Argitaratua 2015
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Activation of Peripheral-Blood Granulocytes Is Strongly Correlated With Patient Outcome After Immunotherapy With Anti-GD2 Monoclonal Antibody and Granulocyte-Macrophage Colony-Stimulating Factor

    Activation of Peripheral-Blood Granulocytes Is Strongly Correlated With Patient Outcome After Immunotherapy With Anti-GD2 Monoclonal Antibody and Granulocyte-Macrophage Colony-Stim... nork Irene Y. Cheung, Katharine C. Hsu, Nai‐Kong V. Cheung

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy

    ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy nork Guilly Rebagay, Su Yan, Cheng Liu, Nai‐Kong V. Cheung

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Sensitivity of Surveillance Studies for Detecting Asymptomatic and Unsuspected Relapse of High-Risk Neuroblastoma

    Sensitivity of Surveillance Studies for Detecting Asymptomatic and Unsuspected Relapse of High-Risk Neuroblastoma nork Brian H. Kushner, Kim Kramer, Shakeel Modak, Nai-KongV. Cheung

    Argitaratua 2009
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Successful Multifold Dose Escalation of Anti-G<sub>D2</sub> Monoclonal Antibody 3F8 in Patients With Neuroblastoma: A Phase I Study

    Successful Multifold Dose Escalation of Anti-G<sub>D2</sub> Monoclonal Antibody 3F8 in Patients With Neuroblastoma: A Phase I Study nork Brian H. Kushner, Kim Kramer, Shakeel Modak, Nai‐Kong V. Cheung

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Irinotecan Plus Temozolomide for Relapsed or Refractory Neuroblastoma

    Irinotecan Plus Temozolomide for Relapsed or Refractory Neuroblastoma nork Brian H. Kushner, Kim Kramer, Shakeel Modak, Nai‐Kong V. Cheung

    Argitaratua 2006
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Bone Marrow Minimal Residual Disease Was an Early Response Marker and a Consistent Independent Predictor of Survival After Anti-GD2 Immunotherapy

    Bone Marrow Minimal Residual Disease Was an Early Response Marker and a Consistent Independent Predictor of Survival After Anti-GD2 Immunotherapy nork Nai‐Kong V. Cheung, Irina Ostrovnaya, Deborah Kuk, Irene Y. Cheung

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: